EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

Alphabet revenue misses expectations, Robinhood Markets says Super Bowl bets are off, and more news to start your day.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

A new artificial intelligence model developed by Stanford Medicine combines clinical notes and pathology images to predict ...